Metcela fetches $12.7m Series B

Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.

Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding. The University of Tokyo Edge Capital Partners led the round.

Source: Press Release